| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/08/2003 | CA2100245C Methods and compositions for the expression of biologically active eukaryotic cytochrome p450s in bacteria |
| 07/08/2003 | CA2080920C Cloning by complementation and related processes |
| 07/08/2003 | CA2076750C Nucleic acid amplification with dna-dependent rna polymerase activity of rna replicases |
| 07/08/2003 | CA2068593C Method for reducing the immunogenicity of antibody variable domains |
| 07/08/2003 | CA2035384C Preparation and use of gene banks of synthetic human antibodies ("synthetic human-antibody libraries") |
| 07/03/2003 | WO2003054755A2 Vaccine for periodontal disease |
| 07/03/2003 | WO2003054744A1 Biological sequence information processing method and device |
| 07/03/2003 | WO2003054550A2 Uses of an endothelial cell receptor |
| 07/03/2003 | WO2003054545A1 Method of detecting antitelomerase antibody |
| 07/03/2003 | WO2003054544A2 Method for determination of the responsiveness of an individual to mistletoe lectin |
| 07/03/2003 | WO2003054542A1 Novel g-protein coupled receptors |
| 07/03/2003 | WO2003054541A2 Inhibition of tristetraproline for protection of the heart from cardiac injuries |
| 07/03/2003 | WO2003054516A2 Devices and methods for isolating and detecting specific substances in complex matrices |
| 07/03/2003 | WO2003054510A2 Method and device for removal of organic molecules |
| 07/03/2003 | WO2003054509A2 Methods and devices for removal of organic molecules from biological mixtures using anion exchange |
| 07/03/2003 | WO2003054234A1 Pcr based high throughput polypeptide screening |
| 07/03/2003 | WO2003054233A1 Late-pcr |
| 07/03/2003 | WO2003054229A2 Maize ccoaomt2 gene polymorphism, and uses thereof to enhance plant digestibility |
| 07/03/2003 | WO2003054226A2 Methods of treating psychosis and schizophrenia based on a polymorphism in the ctf gene |
| 07/03/2003 | WO2003054221A1 Imp dehydrogenase and the use of the same for identifying fungicidally active compounds |
| 07/03/2003 | WO2003054220A1 Reporter gene assay method |
| 07/03/2003 | WO2003054217A2 Plant msh2 sequences and methods of use |
| 07/03/2003 | WO2003054216A2 Antibodies that immunospecifically bind to trail receptors |
| 07/03/2003 | WO2003054213A2 NON-HUMAN PRIMATE Fc RECEPTORS AND METHODS OF USE |
| 07/03/2003 | WO2003054212A2 A method and compositions for conferring viral immunity and reversing viral pathogenesis via strategic infection with a theravirus thereby providing genomic integration of genetically engineered, replication incompetent, integrating viral dna |
| 07/03/2003 | WO2003054211A2 Receptors for hypersensitive response elicitors and uses thereof |
| 07/03/2003 | WO2003054210A2 Regulated nucleic acid expression system |
| 07/03/2003 | WO2003054209A2 A method of reducing non-specific amplification in pcr |
| 07/03/2003 | WO2003054207A2 Fermentation process for the preparation of l-amino acids using coryneform bacteria |
| 07/03/2003 | WO2003054206A1 Process for the preparation of l-amino acids using coryneform bacteria |
| 07/03/2003 | WO2003054203A1 Isolation tool for viable c-kit expressing cells |
| 07/03/2003 | WO2003054201A1 Method for the transformation of vegetable plastids |
| 07/03/2003 | WO2003054200A1 Chitosanase and use thereof |
| 07/03/2003 | WO2003054199A2 Phytases and method for producing these phytases |
| 07/03/2003 | WO2003054198A1 Alleles of the glucokinase gene coryneform bacteria |
| 07/03/2003 | WO2003054197A2 A library of modified structural genes or capsid modified particles useful for the identification of viral clones with desired cell tropism |
| 07/03/2003 | WO2003054196A1 Chitin oligosaccharide elicitor and gibberellin responsive genes in plant and utilization thereof |
| 07/03/2003 | WO2003054195A1 Novel gene useful in diagnosing cancer and use thereof |
| 07/03/2003 | WO2003054194A2 Modified tridegins, production and use thereof as transglutaminase inhibitors |
| 07/03/2003 | WO2003054193A2 Raf/ras binding compounds |
| 07/03/2003 | WO2003054190A1 Novel proteins and dnas thereof |
| 07/03/2003 | WO2003054189A2 Methods for the transformation of vegetal plastids |
| 07/03/2003 | WO2003054188A2 Seminal vesicle tissue-specific promoters and uses thereof |
| 07/03/2003 | WO2003054187A1 Helicase gene |
| 07/03/2003 | WO2003054185A1 Novel alkaline protease from bacillus gibsonii (dsm 14391) and washing and cleaning agents containing said novel alkaline protease |
| 07/03/2003 | WO2003054184A1 Novel alkali protease formed by bacillus gibsonii (dsm 14393) and washing and cleaning agents containing said novel alkali protease |
| 07/03/2003 | WO2003054182A2 Production of butyrylcholinesterases in transgenic mammals |
| 07/03/2003 | WO2003054181A2 Nucleic acid labeling by thermoanaerobacter thermohydrosulfuricus dna polymerase i variants |
| 07/03/2003 | WO2003054180A1 Modified mek1 and mek2, crystal of a peptide: ligand: cofactor complex containing such modified mek1 or mek2, and methods of use thereof |
| 07/03/2003 | WO2003054179A1 Alleles of the siga gene from coryneform bacteria |
| 07/03/2003 | WO2003054177A2 New glycosyl hydrolases |
| 07/03/2003 | WO2003054175A1 Method for the recovery and purification of poxviruses from infected cells |
| 07/03/2003 | WO2003054172A2 Glutamine-auxothrophic human cells capable of producing proteins and capable of growing in a glutamine-free medium |
| 07/03/2003 | WO2003054170A1 Compositions for the in vitro derivation and culture of embryonic stem (es) cell lines with germline transmission capability and for the culture of adult stem cells |
| 07/03/2003 | WO2003054163A2 Methods for producing hyaluronan in a recombinant host cell |
| 07/03/2003 | WO2003054162A2 METHOD AND SYSTEM FOR DEPLETING rRNA POPULATIONS |
| 07/03/2003 | WO2003054161A2 USE OF CpG OLIGODEOXYNUCLEOTIDES TO INDUCE ANGIOGENESIS |
| 07/03/2003 | WO2003054160A2 Cell lines with latent immunodeficiency virus and methods of use thereof |
| 07/03/2003 | WO2003054158A2 Rapidly maturing fluorescent proteins and methods for using the same |
| 07/03/2003 | WO2003054156A2 Novel g proein-coupled receptor, gave7 |
| 07/03/2003 | WO2003054154A2 Antisense modulation of mucin 1, transmembrane expression |
| 07/03/2003 | WO2003054151A2 Generation of transgenic mice by transgene-mediated rescue of spermatogenesis |
| 07/03/2003 | WO2003054148A2 Zinc finger-based drug-dependent gene regulation system |
| 07/03/2003 | WO2003054144A2 Human ras interacting protein |
| 07/03/2003 | WO2003054142A2 Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase |
| 07/03/2003 | WO2003054141A2 Sperm-specific cation channel, catsper2, and uses therefor |
| 07/03/2003 | WO2003054140A2 Phosphate limited inducible promoter and a bacillus expression system |
| 07/03/2003 | WO2003054139A2 Compositions and methods utilizing dna polymerases |
| 07/03/2003 | WO2003054020A2 Human antibodies against human glycoprotein vi and their use |
| 07/03/2003 | WO2003054019A2 Therapeutic monoclonal anti-tirc7 antibodies for use in immune related and other diseases |
| 07/03/2003 | WO2003054018A2 Anti-tirc7 antibodies in therapy of inflammatory diseases |
| 07/03/2003 | WO2003054016A2 Method for cloning of variable domain sequences |
| 07/03/2003 | WO2003054012A2 Leptin proteins |
| 07/03/2003 | WO2003054008A2 Mammalian simp protein, gene sequence and uses thereof in cancer therapy |
| 07/03/2003 | WO2003054007A2 Streptococcus antigens |
| 07/03/2003 | WO2003054006A2 Mutated hiv tat |
| 07/03/2003 | WO2003054004A2 Secreted proteins |
| 07/03/2003 | WO2003054002A1 Peptides for the treatment of cancer associated with the human papilloma virus (hpv) and other epithelial tumours |
| 07/03/2003 | WO2003053997A2 Methods of increasing endogenous erythropoietin (epo) |
| 07/03/2003 | WO2003053921A2 Mutant proteinase inhibitors and uses thereof |
| 07/03/2003 | WO2003053857A1 Forming and modifying dielctrically-engineered microparticles |
| 07/03/2003 | WO2003053586A1 Array plates and method for constructing array plates |
| 07/03/2003 | WO2003053476A1 Adeno-associated virus-mediated delivery of gdnf to skeletal muscles |
| 07/03/2003 | WO2003053467A1 Drug for regenerating tissue and vessel and method therefor |
| 07/03/2003 | WO2003053409A1 Liposome composition for delivery of nucleic acid |
| 07/03/2003 | WO2003053365A2 Syn3 compositions and methods |
| 07/03/2003 | WO2003053364A2 Methods and compositions in treating pain and painful disorders using 1465,1587, 2146, 2207, 32838, 336 and 52908 |
| 07/03/2003 | WO2003053342A2 Antisense modulation of cd81 expression |
| 07/03/2003 | WO2003053341A2 Antisense modulation of ship-1 expression |
| 07/03/2003 | WO2003053340A2 Antisense modulation of connective tissue growth factor expression |
| 07/03/2003 | WO2003053338A2 Novel chimeric rev, tat, and nef antigens |
| 07/03/2003 | WO2003053332A2 Composition and method for treating viral infection |
| 07/03/2003 | WO2003053224A2 Novel compositions and methods for cancer |
| 07/03/2003 | WO2003053215A2 Diagnosis prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling |
| 07/03/2003 | WO2003053139A1 Disruption of the phosphodiesterase 10 gene |
| 07/03/2003 | WO2003053138A1 Transgenic expression of glycogen synthase kinase 3 in muscle |
| 07/03/2003 | WO2003053136A2 Triple transgenic mouse model of alzheimer's disease |
| 07/03/2003 | WO2003053135A1 Plant xrcc3 genes and methods of use |
| 07/03/2003 | WO2003041490A3 Novel isoamylases and associated methods and products |
| 07/03/2003 | WO2003035881A3 Stress tolerant plants |